TNDM compared with AXGN: revenue, margins and what each company keeps, and the suppliers and customers both name

TNDMTandem Diabetes Care Inc

Mkt capRevenueRevenue

AXGNAxogen, Inc.

Mkt capRevenueRevenue

Compare

TNDMTandem Diabetes Care Inc

AXGNAxogen, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TNDM

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±17.0%▲+19.11%×1.12

Q1 FY26±19.9%▼−16.19%×0.81

Feb 20 '26±13.6%▲+32.67%×2.40

Q3 FY25±22.0%▲+21.98%×1.00

AXGN

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±19.5%▲+31.47%×1.62

Q2 FY26±16.1%▲+0.53%×0.03

= impliedTNDM realized, solidAXGN realized, hatchedOne scale, both sides: full bar = 33%× = |realized| ÷ impliedSource: market data

Q1 FY26

±15.4%

▲+6.60%

×0.43

Feb 24 '26±13.3%▼−8.14%×0.61

TNDMTandem Diabetes Care Inc

19.10▼−3.48%· post 19.10

Mkt cap$1.3BRevenue$255MQ2 FY26Revenue$1.0BFY25

AXGNAxogen, Inc.

49.37▼−0.52%· post 49.37

ClosedOct 30 '26

Mkt cap$2.9BRevenue$76MQ3 FY26Revenue$225MFY25

Compare

ClosedOct 30 '26

TNDMTandem Diabetes Care Inc

AXGNAxogen, Inc.

19.10▼−3.48%post 19.10

Price

49.37▼−0.52%post 49.37

$1.3B

Mkt cap

$2.9B

Q2 FY26$255M

Revenue

$76MQ3 FY26

FY25$1.0B

Revenue

$225MFY25

TNDM19.10▼−3.48%vsAXGN49.37▼−0.52%ClosedOct 30 '26